Diane E. Cryderman
University of Iowa
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Diane E. Cryderman.
The EMBO Journal | 1999
Diane E. Cryderman; Eric Morris; Harald Biessmann; Sarah C. R. Elgin; Lori L. Wallrath
Transgenes inserted into the telomeric regions of Drosophila melanogaster chromosomes exhibit position effect variegation (PEV), a mosaic silencing characteristic of euchromatic genes brought into juxtaposition with heterochromatin. Telomeric transgenes on the second and third chromosomes are flanked by telomeric associated sequences (TAS), while fourth chromosome telomeric transgenes are most often associated with repetitious transposable elements. Telomeric PEV on the second and third chromosomes is suppressed by mutations in Su(z)2, but not by mutations in Su(var)2‐5 (encoding HP1), while the converse is true for telomeric PEV on the fourth chromosome. This genetic distinction allowed for a spatial and molecular analysis of telomeric PEV. Reciprocal translocations between the fourth chromosome telomeric region containing a transgene and a second chromosome telomeric region result in a change in nuclear location of the transgene. While the variegating phenotype of the white transgene is suppressed, sensitivity to a mutation in HP1 is retained. Corresponding changes in the chromatin structure and inducible activity of an associated hsp26 transgene are observed. The data indicate that both nuclear organization and local chromatin structure play a role in this telomeric PEV.
Journal of Biological Chemistry | 2008
Hongbo Yang; James J. Pesavento; Taylor W. Starnes; Diane E. Cryderman; Lori L. Wallrath; Neil L. Kelleher; Craig A. Mizzen
Post-translational modifications of histone tails direct nuclear processes including transcription, DNA repair, and chromatin packaging. Lysine 20 of histone H4 is mono-, di-, or trimethylated in vivo, but the regulation and significance of these methylations is poorly understood. The SET domain proteins PR-Set7 and Suv4-20 have been implicated in mono- and trimethylation, respectively; however, enzymes that dimethylate lysine 20 have not been identified. Here we report that Drosophila Suv4-20 is a mixed product specificity methyltransferase that dimethylates ∼90% and trimethylates less than 5% of total H4 at lysine 20 in S2 cells. Trimethylation, but not dimethylation, is reduced in Drosophila larvae lacking HP1, suggesting that an interaction with HP1 regulates the product specificity of Suv4-20 and enrichment of trimethyllysine 20 within heterochromatin. Similar to the Drosophila enzyme, human Suv4-20h1/h2 enzymes generate di- and trimethyllysine 20. PR-Set7 and Suv4-20 are both required for normal levels of methylation, suggesting they have non-redundant functions. Alterations in the level of lysine 20 methylation following knock-down or overexpression of Suv4-20 did not affect lysine 16 acetylation, revealing that these two modifications are not competitive in vivo. Depletion of Suv4-20h1/h2 in HeLa cells impaired the formation of 53BP1 foci, suggesting dimethyllysine 20 is required for a proper DNA damage response. Collectively, the data indicate that Suv4-20 generates nearly ubiquitous dimethylation that facilitates the DNA damage response and selective trimethylation that is involved in heterochromatin formation.
Developmental Dynamics | 2005
Diane E. Cryderman; Stephanie K Grade; Yuhong Li; Laura Fanti; Sergio Pimpinelli; Lori L. Wallrath
Heterochromatin protein 1 (HP1), a gene silencing protein, localizes to centric heterochromatin through an interaction with methylated K9 of histone H3, a modification generated by the histone methyl transferase SU(VAR)3‐9. On Drosophila polytene chromosomes, HP1 also localizes to 200 sites scattered throughout euchromatin. To address the role of HP1 in euchromatic gene regulation, mRNAs from wild‐type and Su(var)2‐5 mutants lacking HP1 were compared. Genes residing within a 550‐kb genomic region enriched in HP1 that show altered expression in the Su(var)2‐5 mutant were analyzed in detail. Three genes within this region, Pros35, CG5676, and cdc2, were found to associate with HP1 by chromatin immunoprecipitation. Surprisingly, these genes require HP1 for expression, suggesting a positive role for HP1 in euchromatic gene expression. Of these genes, only cdc2 is packaged with methylated K9 H3. Furthermore, none of the genes show altered expression in a Su(var)3‐9 mutant. Collectively, these data demonstrate multiple mechanisms for HP1 localization within euchromatin and show that some genes associated with HP1 are not affected by alterations in Su(var)3‐9 dosage. Developmental Dynamics 232:767–774, 2005.
Chromosoma | 1998
Diane E. Cryderman; Matthew H. Cuaycong; Sarah C. R. Elgin; Lori L. Wallrath
Abstract. In a variety of organisms, euchromatic genes brought into juxtaposition with pericentric heterochromatin show position-effect variegation (PEV), a silencing of gene expression in a subset of the cells in which the gene is normally expressed. Previously, a P-element mobilization screen identified transgenic Drosophila stocks showing PEV of an hsp70-white+ reporter gene; transgenes in many of these stocks map to the chromocenter of polytene chromosome. A screen at an elevated temperature identified two stocks that under standard culture temperatures show complete repression of the hsp70-white+ transgene. The transgenes in both cases map to the chromocenter of polytene chromosomes. Different types of middle repetitive elements are adjacent to seven pericentric transgenes; unique sequences are adjacent to two of the perimetric transgenes. All of the transgenes show suppression of PEV in response to a mutation in the gene encoding heterochromatin protein 1 (HP1). This suppression correlates with a more accessible chromatin structure. The results indicate that a pericentric transgene showing PEV can be associated with different types of DNA sequences, while maintaining a common association with the chromosomal protein HP1.
Journal of Biological Chemistry | 2014
Abdelhamid M. Azzaz; Michael W. Vitalini; Andrew S. Thomas; Jason P. Price; Melissa J. Blacketer; Diane E. Cryderman; Luka N. Zirbel; Christopher L. Woodcock; Adrian H. Elcock; Lori L. Wallrath; Michael A. Shogren-Knaak
Background: Heterochromatin is enriched for di- and tri-methylated lysine 9 of histone H3 (H3K9Me2/3) and heterochromatin protein 1 (HP1Hsα .). Results: The association of HP1Hsα with H3K9Me3-containing nucleosome arrays facilitated array compaction and cross-array interactions. Conclusion: HP1Hsα association caused intra- and inter-array associations, leading to chromatin condensation and looping. Significance: An understanding of HP1Hsα-nucleosome interactions provides insights on the structure and functions of heterochromatin. HP1Hsα-containing heterochromatin is located near centric regions of chromosomes and regulates DNA-mediated processes such as DNA repair and transcription. The higher-order structure of heterochromatin contributes to this regulation, yet the structure of heterochromatin is not well understood. We took a multidisciplinary approach to determine how HP1Hsα-nucleosome interactions contribute to the structure of heterochromatin. We show that HP1Hsα preferentially binds histone H3K9Me3-containing nucleosomal arrays in favor of non-methylated nucleosomal arrays and that nonspecific DNA interactions and pre-existing chromatin compaction promote binding. The chromo and chromo shadow domains of HP1Hsα play an essential role in HP1Hsα-nucleosome interactions, whereas the hinge region appears to have a less significant role. Electron microscopy of HP1Hsα-associated nucleosomal arrays showed that HP1Hsα caused nucleosome associations within an array, facilitating chromatin condensation. Differential sedimentation of HP1Hsα-associated nucleosomal arrays showed that HP1Hsα promotes interactions between arrays. These strand-to-strand interactions are supported by in vivo studies where tethering the Drosophila homologue HP1a to specific sites promotes interactions with distant chromosomal sites. Our findings demonstrate that HP1Hsα-nucleosome interactions cause chromatin condensation, a process that regulates many chromosome events.
Journal of Biological Chemistry | 2013
Rebecca L. Fagan; Diane E. Cryderman; Levy Kopelovich; Lori L. Wallrath; Charles Brenner
Background: Approved DNA demethylators do not directly inhibit Dnmt1, an oncogenic methyltransferase. Results: Laccaic acid A (LCA) is a direct, DNA-competitive Dnmt1 inhibitor that reactivates genes silenced by DNA methylation in breast cancer cells synergistically with 5-azadC. Conclusion: LCA is a natural product in a new class of Dnmt1-targeting small molecules. Significance: By directly inhibiting Dnmt1, we may reveal and block specific carcinogenesis pathways. Methylation of cytosines in CpG dinucleotides is the predominant epigenetic mark on vertebrate DNA. DNA methylation is associated with transcriptional repression. The pattern of DNA methylation changes during development and with disease. Human DNA methyltransferase 1 (Dnmt1), a 1616-amino acid multidomain enzyme, is essential for maintenance of DNA methylation in proliferating cells and is considered an important cancer drug target. Using a fluorogenic, endonuclease-coupled DNA methylation assay with an activated form of Dnmt1 engineered to lack the replication foci targeting sequence domain, we discovered that laccaic acid A (LCA), a highly substituted anthraquinone natural product, is a direct inhibitor with a 310 nm Ki. LCA is competitive with the DNA substrate in in vitro methylation assays and alters the expression of methylated genes in MCF-7 breast cancer cells synergistically with 5-aza-2′-deoxycytidine. LCA represents a novel class of Dnmt-targeted molecular probes, with biochemical properties that allow it to distinguish between non DNA-bound and DNA-bound Dnmt1.
PLOS ONE | 2009
Sandra R. Schulze; Beatrice Curio-Penny; Sean D. Speese; George Dialynas; Diane E. Cryderman; Caitrin W. McDonough; Demet Nalbant; Melissa Petersen; Vivian Budnik; Pamela K. Geyer; Lori L. Wallrath
Nuclear intermediate filament proteins, called lamins, form a meshwork that lines the inner surface of the nuclear envelope. Lamins contain three domains: an N-terminal head, a central rod and a C-terminal tail domain possessing an Ig-fold structural motif. Lamins are classified as either A- or B-type based on structure and expression pattern. The Drosophila genome possesses two genes encoding lamins, Lamin C and lamin Dm0, which have been designated A- and B-type, respectively, based on their expression profile and structural features. In humans, mutations in the gene encoding A-type lamins are associated with a spectrum of predominantly tissue-specific diseases known as laminopathies. Linking the disease phenotypes to cellular functions of lamins has been a major challenge. Drosophila is being used as a model system to identify the roles of lamins in development. Towards this end, we performed a comparative study of Drosophila and human A-type lamins. Analysis of transgenic flies showed that human lamins localize predictably within the Drosophila nucleus. Consistent with this finding, yeast two-hybrid data demonstrated conservation of partner-protein interactions. Drosophila lacking A-type lamin show nuclear envelope defects similar to those observed with human laminopathies. Expression of mutant forms of the A-type Drosophila lamin modeled after human disease-causing amino acid substitutions revealed an essential role for the N-terminal head and the Ig-fold in larval muscle tissue. This tissue-restricted sensitivity suggests a conserved role for lamins in muscle biology. In conclusion, we show that (1) localization of A-type lamins and protein-partner interactions are conserved between Drosophila and humans, (2) loss of the Drosophila A-type lamin causes nuclear defects and (3) muscle tissue is sensitive to the expression of mutant forms of A-type lamin modeled after those causing disease in humans. These studies provide new insights on the role of lamins in nuclear biology and support Drosophila as a model for studies of human laminopathies involving muscle dysfunction.
Methods in Enzymology | 1999
Iain L. Cartwright; Diane E. Cryderman; David S. Gilmour; Lori A. Pile; Lori L. Wallrath; Janet A. Weber; Sarah C. R. Elgin
Publisher Summary This chapter presents the analysis of Drosophila chromatin structure in vivo . Gene activation in vivo is a complex process. The chapter discusses in detail approaches for mapping chromatin structure, both at the level of nucleosome arrays and at the level of base-pair resolution, using cells or nuclei isolated from Drosophila at different stages of the life cycle. An in vivo analysis of chromatin structure and its functional role in regulating the expression of a given gene requires the exploitation of genetic tools whereby the effects of sequence alterations within the putative regulatory region and of mutations in the proposed trans -acting regulatory proteins can be examined. The extensive genetic information available and the ability to return an altered gene to the genome by P-element transformation make Drosophila an excellent system for these types of functional studies. The chapter describes the process of identifying major embryonic chromatin structural features at specific loci.
Genetics | 2009
Karrie A. Hines; Diane E. Cryderman; Kaitlin M. Flannery; Hongbo Yang; Michael W. Vitalini; Tulle Hazelrigg; Craig A. Mizzen; Lori L. Wallrath
Centric regions of eukaryotic genomes are packaged into heterochromatin, which possesses the ability to spread along the chromosome and silence gene expression. The process of spreading has been challenging to study at the molecular level due to repetitious sequences within centric regions. A heterochromatin protein 1 (HP1) tethering system was developed that generates “ectopic heterochromatin” at sites within euchromatic regions of the Drosophila melanogaster genome. Using this system, we show that HP1 dimerization and the PxVxL interaction platform formed by dimerization of the HP1 chromo shadow domain are necessary for spreading to a downstream reporter gene located 3.7 kb away. Surprisingly, either the HP1 chromo domain or the chromo shadow domain alone is sufficient for spreading and silencing at a downstream reporter gene located 1.9 kb away. Spreading is dependent on at least two H3K9 methyltransferases, with SU(VAR)3-9 playing a greater role at the 3.7-kb reporter and dSETDB1 predominately acting at the 1.9 kb reporter. These data support a model whereby HP1 takes part in multiple mechanisms of silencing and spreading.
Journal of Investigative Dermatology | 2015
Jens Bohnekamp; Diane E. Cryderman; Achim Paululat; Gabriel C. Baccam; Lori L. Wallrath; Thomas M. Magin
The blistering skin disorder Epidermolysis bullosa simplex (EBS) results from dominant mutations in K5 or K14 genes, encoding the intermediate filament network of basal epidermal keratinocytes. The mechanisms governing keratin network formation and collapse due to EBS mutations remain incompletely understood. Drosophila lacks cytoplasmic intermediate filaments, providing a ‚null’ environment to examine the formation of keratin networks and determine mechanisms by which mutant keratins cause pathology. Here, we report that ubiquitous co-expression of transgenes encoding wild-type human K14 and K5 resulted in the formation of extensive keratin networks in Drosophila epithelial and non-epithelial tissues, causing no overt phenotype. Similar to mammalian cells, treatment of transgenic fly tissues with phosphatase inhibitors caused keratin network collapse, validating Drosophila as a genetic model system to investigate keratin dynamics. Co-expression of K5 and a K14R125C mutant that causes the most severe form of EBS resulted in widespread formation of EBS-like cytoplasmic keratin aggregates in epithelial and non-epithelial fly tissues. Expression of K14R125C/K5 caused semi-lethality; adult survivors developed wing blisters and were flightless due to lack of intercellular adhesion during wing heart development. This Drosophila model of EBS is valuable for the identification of pathways altered by mutant keratins and for development of EBS therapies.